Expression of MMP-2, -7, -9, MT1-MMP and TIMP-1 and -2 has no prognostic relevance in patients with advanced epithelial ovarian cancer

Author：            

Publisher： Spandidos Publications

ISSN： 1021-335X

Source： Oncology Reports, Vol.27, Iss.4, 2012-01, pp. : 1049-1057

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

High levels of MMP-2, MMP-9, MT1-MMP and TIMP-2 mRNA correlate with poor survival in ovarian carcinoma

By Davidson Ben   Goldberg Iris   Gotlieb Walter   Kopolovic Juri   Ben-Baruch Gilad   Nesland Jahn   Berner Aasmund   Bryne Magne   Reich Reuven  

Clinical and Experimental Metastasis, Vol. 17, Iss. 10, 1999-12 ,pp. : 799-808

Springer Publishing Company

Access to resources Recommend Favorite

Evaluation of MMP2, MMP9, TIMP1, TIMP2, NGAL and MMP9/NGAL complex in urine and sera from patients with bladder cancer

By      

Oncology Letters, Vol. 10, Iss. 4, 2015-01 ,pp. : 2527-2532

Spandidos Publications

Access to resources Recommend Favorite

Activation of Tolllike receptor 7 regulates the expression of IFNλ1, p53, PTEN, VEGF, TIMP1 and MMP9 in pancreatic cancer cells

By                

Molecular Medicine Reports, Vol. 13, Iss. 2, 2016-01 ,pp. : 1807-1812

Spandidos Publications

Access to resources Recommend Favorite

Norcantharidin enhances TIMP2 antivasculogenic mimicry activity for human gallbladder cancers through downregulating MMP2 and MT1MMP

By  

International Journal of Oncology, Vol. 46, Iss. 2, 2015-01 ,pp. : 627-640

Spandidos Publications

Access to resources Recommend Favorite

MMP-2 and MMP-9 Expression in Breast Cancer-Derived Human Fibroblasts is Differentially Regulated by Stromal-Epithelial Interactions

By Singer C.F.  

Breast Cancer Research and Treatment, Vol. 72, Iss. 1, 2002-03 ,pp. : 69-77

Springer Publishing Company

Access to resources Recommend Favorite